Differences in risk factors for epithelial ovarian cancer by histologic type: Results of a case-control study

American Journal of Epidemiology

Volumn 144, Issue 4, 1996, Pages 363-372

  Risch, Harvey A ^a   Marrett, Loraine D ^b   Jain, Meera ^c   Howe, Geoffrey R ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ontario Cancer Treatment and Research Foundation   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

contraception; diet; histology; ovarian neoplasms; parity; pregnancy; retrospective studies

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIETARY INTAKE; ENDOMETRIOID CARCINOMA; FAT INTAKE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CANCER; PREGNANCY; RISK FACTOR;

EID: 0029785785     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008937     Document Type: Article

References (50)

1. Hart WR. Pathology of malignant and borderline (low malignant potential) epithelial tumors of ovary. In: Coppleson M, ed. Gynecologic oncology: fundamental principles and clinical practice. 2nd ed. Vol 2. New York, NY: Churchill Living-stone, 1992:863-87.
2. Harris R, Whittemore AS, Itnyre J, et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992;136: 1204-11.
3. Whittemore AS, Harris R, Itnyre J, et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;136:1184-203.
4. Björkholm E, Pettersson F, Einhorn N, et al. Long-term follow-up and prognostic factors in ovarian carcinoma: the Radiumhemmet series 1958 to 1973. Acta Radiol Oncol 1982; 21:413-19.
5. Wertheim I, Muto MG, Welch WR, et al. p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst 1994;86:1549-51.
6. Cramer DW, Hutchison GB, Welch WR, et al. Factors affecting the association of oral contraceptives and ovarian cancer. N Engl J Med 1982;307:1047-51.
7. Kvåle G, Heuch I, Nilssen S, et al. Reproductive factors and risk of ovarian cancer: a prospective study. Int J Cancer 1988;42:246-51.
8. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Epithelial ovarian cancer and combined oral contraceptives. Int J Epidemiol 1989;18:538-45.
9. Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994;140:585-97.
10. Risch HA, Jain M, Marrett LD, et al. Dietary fat intake and risk of epithelial ovarian cancer. J Natl Cancer Inst 1994;86: 1409-15.
11. Morgan RW, Jain M, Miller AB, et al. A comparison of dietary methods in epidemiologic studies. Am J Epidemiol 1978;107:488-98.
12. Jain M, Howe GR, Harrison L, et al. A study of repeatability of dietary data over a seven-year period. Am J Epidemiol 1989;129:422-9.
13. World Health Organization. ICD-O: international classification of diseases for oncology. (Field trial edition). Bethesda, MD: National Cancer Institute, 1988.
14. Baker RJ, Nelder JA. The GLIM system. Release 3. Oxford, England: Royal Statistical Society, 1978.
15. Fox J. Linear statistical models and related methods: with applications to social research. New York, NY: John Wiley and Sons, Inc, 1984:313-15.
16. Barber HRK. Ovarian carcinoma: etiology, diagnosis and treatment. 3rd ed. New York, NY: Springer-Verlag New York, 1993:45-53.
17. Bostwick DG, Tazelaar HD, Ballon SC, et al. Ovarian epithelial tumors of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer 1986;58:2052-65.
18. Katsube Y, Berg JW, Silverberg SG. Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979. Int J Gynecol Pathol 1982;1:3-16.
19. Harlow BL, Weiss NS, Roth GJ, et al. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones. Cancer Res 1988;48: 5849-52.
20. McGowan L, Parent L, Lednar W, et al. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979;7:325-44.
21. Cramer DW, Welch WR, Scully RE, et al. Ovarian cancer and talc: a case-control study. Cancer 1982;50:372-6.
22. Weiss NS, Lyon JL, Krishnamurthy S, et al. Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst 1982;68:95-8.
23. Cramer DW, Hutchison GB, Welch WR, et al. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 1983;71:711-16.
24. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: a case-control study. Br J Cancer 1989;60:592-8.
25. Schiffman MH, Hartge P, Hoover RN, et al. Epithelial ovarian cancer. (Letter). Gynecol Oncol 1989;33:129-32.
26. Levi F, Franceschi S, La Vecchia C, et al. Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland. Ann Oncol 1993;4:289-94.
27. Sakamoto A, Sasaki H, Furusato M, et al. Observer disagreement in histological classification of ovarian tumors in Japan. Gynecol Oncol 1994;54:54-8.
28. Weiss NS, Lyon JL, Liff JM, et al. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer 1981;28:669-71.
29. Weiss NS, Young JL Jr, Roth GJ. Marital status and incidence of ovarian cancer: the U.S. Third National Cancer Survey, 1969-71. J Natl Cancer Inst 1977;58:913-15.
30. Narod SA, Madlensky L, Bradley L, et al. Hereditary and familial ovarian cancer in southern Ontario. Cancer 1994;74: 2341-6.
31. Greggi S, Genuardi M, Benedetti-Panici P, et al. Analysis of 138 consecutive ovarian cancer patients: incidence and characteristics of familial cases. Gynecol Oncol 1990;39:300-4.
32. Bewtra C, Watson P, Conway T, et al. Hereditary ovarian cancer: a clinicopathological study. Int J Gynecol Pathol 1992; 11:180-7.
33. Piver MS, Baker TR, Jishi MF, et al. Familial ovarian cancer: a report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991. Cancer 1993;71:582-8.
34. Narod S, Tonin P, Lynch H, et al. Histology of BRCA1-associated ovarian tumours. (Letter). Lancet 1994;343:236.
35. Annegers JF, Strom H, Decker DG, et al. Ovarian cancer: incidence and case-control study. Cancer 1979;43:723-9.
36. Tzonou A, Day NE, Trichopoulos D, et al. The epidemiology of ovarian cancer in Greece: a case-control study. Eur J Cancer Clin Oncol 1984;20:1045-52.
37. Kaufman DW, Kelly JP, Welch WR, et al. Noncontraceptive estrogen use and epithelial ovarian cancer. Am J Epidemiol 1989;130:1142-51.
38. Parazzini F, La Vecchia C, Negri E, et al. Estrogen replacement therapy and ovarian cancer risk. (Letter). Int J Cancer 1994;57:135-6.
39. Parmley TH, Woodruff JD. The ovarian mesothelioma. Am J Obstet Gynecol 1974;120:234-41.
40. Godwin AK, Testa JR, Hamilton TC. The biology of ovarian cancer development. Cancer 1993;71:530-6.
41. Kjaer SK, Brinton LA. Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 1993;15:486-98.
42. Yamakawa Y, Forslund O, Teshima H, et al. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol 1994;53:190-5.
43. Brinton LA, Huggins GR, Lehman HF, et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986;38:339-44.
44. Brinton LA, Reeves WC, Brenes MM, et al. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol 1990;19:4-11.
45. Ursin G, Peters RK, Henderson BE, et al. Oral contraceptive use and adenocarcinoma of the cervix. Lancet 1994;344: 1390-4.
46. Brinton LA, Tashima KT, Lehman HF, et al. Epidemiology of cervical cancer by cell type. Cancer Res 1987;47:1706-11.
47. Kvåle G, Heuch I, Nilssen S. Reproductive factors and risk of cervical cancer by cell type: a prospective study. Br J Cancer 1988;58:820-4.
48. Parazzini F, La Vecchia C, Negri E, et al. Risk factors for adenocarcinoma of the cervix: a case-control study. Br J Cancer 1988;57:201-4.
49. Farrow DC, Weiss NS, Lyon JL, et al. Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol 1989:129:1300-4.
50. Lash RH, Hart WR. Intestinal adenocarcinomas metastatic to the ovaries: a clinicopathologic evaluation of 22 cases. Am J Surg Pathol 1987;11:114-21.